ArticleMolecular medicine reports2017

Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.

Ga Bin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.